Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Glucagonoma MeSH Descriptor Data 2025


MeSH Heading
Glucagonoma
Tree Number(s)
C04.557.470.200.025.290.750
C04.588.274.761.500.249
C04.588.322.475.500.249
C06.301.761.500.249
C06.689.667.500.249
C19.344.421.500.249
Unique ID
D005935
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D005935
Annotation
coordinate IM with PANCREATIC NEOPLASMS (IM); for glucagonoma syndrome, coordinate also with NECROLYTIC MIGRATORY ERYTHEMA
Scope Note
An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.
Entry Term(s)
Adenoma, alpha-Cell
Glucagonoma Syndrome
alpha-Cell Tumor
NLM Classification #
WI 810
Previous Indexing
Islet Cell Tumor (1966-1981)
See Also
Necrolytic Migratory Erythema
Public MeSH Note
91; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981
Online Note
search ISLET CELL TUMOR 1981
History Note
91(82); was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981
Date Established
1991/01/01
Date of Entry
1981/05/20
Revision Date
2012/07/03
Glucagonoma Preferred
page delivered in 0.136s